FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to des(B30) human insulin derivatives which have a side chain attached to ε-amino group of a lysine residue found in a B-chain of initial insulin, wherein this side chain has general formula -W-X-Y-Z, wherein W, X, Y and Z are those as specified in the description.
EFFECT: preparing the des(B30) human insulin derivatives.
16 cl, 4 tbl, 37 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INSULIN DERIVATIVES | 2004 |
|
RU2352581C2 |
| TREATING DIABETES MELLITUS BY INSULIN INJECTIONS AS LITTLE AS ONCE DAY | 2009 |
|
RU2540922C2 |
| PHARMACEUTICAL COMPOSITION | 2013 |
|
RU2670106C2 |
| METHOD OF OBTAINING INSULIN ZINC COMPLEXES | 2011 |
|
RU2572214C2 |
| INSULIN DERIVATIVE, SOLUBLE PROLONGED PHARMACEUTICAL COMPOSITION, METHOD OF PROLONGATION OF HYPOGLYCAEMIC EFFECT IN TREATMENT OF DIABETIC PATIENTS | 1994 |
|
RU2164520C2 |
| ACYLATED INSULIN ANALOGUES STABILISED WITH RESPECT TO PROTEASES | 2009 |
|
RU2571857C2 |
| INSULIN CONJUGATES | 2019 |
|
RU2809189C2 |
| METHOD OF CONJUGATING PEPTIDES, MEDIATED BY TRANSGLUTAMINASE | 2005 |
|
RU2385879C2 |
| INSULIN PURIFICATION | 2012 |
|
RU2603752C2 |
| BINDER FOR PEPTIDES | 2019 |
|
RU2808687C2 |
